We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
41 hedge funds and large institutions have $180M invested in Evelo Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
590% more call options, than puts
Call options by funds: $207K | Put options by funds: $30K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $180M → $180M (-$383K)
11% less funds holding
Funds holding: 46 → 41 (-5)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
41
Holders Change
-5
Holders Change %
-10.87%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
10
Reduced
13
Closed
11
Calls
$207K
Puts
$30K
Net Calls
+$177K
Net Calls Change
+$18K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.26M |
| 2 |
BlackRock
New York
|
+$673K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$548K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$241K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$52.9K |
Top Sellers
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$826K |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$716K |
| 3 |
E
Ergoteles
New York
|
-$633K |
| 4 |
Norges Bank
Oslo,
Norway
|
-$621K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$423K |
